SCHEMBL946992

SCHEMBL946992

CCCCCCCCC(=O)NN

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.65
HSP90AA1 P07900 1/20 0.64
FAAH O00519 4/20 0.61
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
MAPK1 P28482 1/20 0.57
ALDH1A1 P00352 3/20 0.55
DNM1 Q05193 1/20 0.55
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
PPARG P37231 6/20 0.52
PPARD Q03181 6/20 0.52
PPARA Q07869 6/20 0.52
GPR84 Q9NQS5 5/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 4/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
PTPN1 P18031 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519669 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL998990 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL945586 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL2920943 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL3110219 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL1272524 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL944700 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL765863 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
SCHEMBL765585 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A
Tetradecanehydrazide SCHEMBL945985 1.00 CTSD (0.65) CTSDHSP90AA1FAAHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1658866-A Tri-substituted heteroaryls and methods of making and using the same BIOGEN INC (US) 2005-08-24 CN claimed
US-12617762-B2 Carboxy derivatives with antiinflamatory properties SITRYX THERAPEUTICS LIMITED (GB) 2026-05-05 US disclosed
EP-4081511-B3 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LTD (GB) 2026-03-04 EP disclosed
US-20250215572-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY SHIKOKU CHEMICALS CORPORATION (JP) 2025-07-03 US disclosed
EP-4506488-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY Shikoku Chemicals Corporation (JP) 2025-02-12 EP disclosed
CN-118922584-A Surface treating agent for copper or copper alloy 四国化成工业株式会社 2024-11-08 CN disclosed
EP-4442319-A2 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES Sitryx Therapeutics Limited (GB) 2024-10-09 EP disclosed
EP-4081511-B1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LTD (GB) 2024-07-31 EP disclosed
EP-3952872-B1 CARBAMOYL CYCLOHEXANE DERIVATIVES FOR TREATING AUTISM SPECTRUM DISORDER RICHTER GEDEON NYRT (HU) 2024-03-13 EP disclosed
EP-4073178-B1 LOW TEMPERATURE CURE COATING COMPOSITIONS PPG IND OHIO INC (US) 2024-01-31 EP disclosed
EP-0609441-B1 Oxazolidone derivatives as monoamine oxidase inhibitors EISAI CO LTD (JP) 1999-07-21 EP disclosed
US-5475014-A Monoamine oxidase inhibor; antidepressant EISAI CO., LTD. (JP) 1995-12-12 US disclosed
EP-0609441-A1 OXAZOLIDONE DERIVATIVE Eisai Co., Ltd. (JP) 1994-08-10 EP disclosed
US-5075030-A Mixtures CANON KABUSHIKI KAISHA (JP) 1991-12-24 US disclosed
EP-0321928-A2 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines E.R. SQUIBB & SONS, INC. (US) 1989-06-28 EP disclosed
EP-0303286-A1 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines E.R. Squibb & Sons, Inc. (US) 1989-02-15 EP disclosed
US-4777252-A 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines E. R. SQUIBB & SONS, INC. (US) 1988-10-11 US disclosed
US-4772693-A 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines E. R. SQUIBB & SONS, INC. (US) 1988-09-20 US disclosed
US-4743685-A 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines E. R. SQUIBB & SONS, INC. (US) 1988-05-10 US disclosed
US-3931313-A HERBICIDE ANTIDOTES STAUFFER CHEMICAL COMPANY (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617762-B2 Carboxy derivatives with antiinflamatory properties CCR1, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CTSD 2120/4885HSP90AA1 507/4885FAAH 770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.